|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 7/28/22 West Pharmaceutical Services Inc. 10-Q 6/30/22 83:9.6M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 997K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 25K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 25K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 22K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 22K
11: R1 Cover Page HTML 74K
12: R2 Condensed Consolidated Statements of Income HTML 101K
(Unaudited)
13: R3 Condensed Consolidated Statements of Comprehensive HTML 55K
Income (Unaudited)
14: R4 Condensed Consolidated Statements of Comprehensive HTML 34K
Income (Unaudited) (Parenthetical)
15: R5 Condensed Consolidated Balance Sheets (Unaudited) HTML 154K
16: R6 Condensed Consolidated Balance Sheets (Unaudited) HTML 39K
(Parenthetical)
17: R7 Condensed Consolidated Statements of Cash Flows HTML 92K
(Unaudited)
18: R8 Basis of Presentation and Summary of Significant HTML 27K
Accounting Policies
19: R9 New Accounting Standards HTML 35K
20: R10 Revenue HTML 63K
21: R11 Net Income Per Share HTML 37K
22: R12 Inventories HTML 29K
23: R13 Leases HTML 59K
24: R14 Affiliated Companies HTML 27K
25: R15 Debt HTML 45K
26: R16 Derivative Financial Instruments HTML 134K
27: R17 Fair Value Measurements HTML 82K
28: R18 Accumulated Other Comprehensive Loss HTML 101K
29: R19 Shareholders' Equity HTML 145K
30: R20 Stock-Based Compensation HTML 28K
31: R21 Benefit Plans HTML 116K
32: R22 Other (Income) Expense HTML 52K
33: R23 Income Taxes HTML 26K
34: R24 Commitments and Contingencies HTML 25K
35: R25 Segment Information HTML 76K
36: R26 Basis of Presentation and Summary of Significant HTML 30K
Accounting Policies (Policies)
37: R27 Revenue (Tables) HTML 59K
38: R28 Net Income Per Share (Tables) HTML 35K
39: R29 Inventories (Tables) HTML 30K
40: R30 Leases (Tables) HTML 62K
41: R31 Debt (Tables) HTML 35K
42: R32 Derivative Financial Instruments (Tables) HTML 136K
43: R33 Fair Value Measurements (Tables) HTML 75K
44: R34 Accumulated Other Comprehensive Loss (Tables) HTML 102K
45: R35 Shareholders' Equity (Tables) HTML 141K
46: R36 Benefit Plans (Tables) HTML 105K
47: R37 Other (Income) Expense (Tables) HTML 51K
48: R38 Segment Information (Tables) HTML 70K
49: R39 Revenue - Revenue Recognition (Details) HTML 58K
50: R40 Revenue - Contracts and Liabilities (Details) HTML 33K
51: R41 Revenue - Narrative (Details) HTML 34K
52: R42 Net Income Per Share - Summary of Net Income Per HTML 43K
Share (Details)
53: R43 Net Income Per Share - Narrative (Details) HTML 34K
54: R44 Inventories (Details) HTML 31K
55: R45 Leases - Lease Cost (Details) HTML 31K
56: R46 Leases - Lease Cash Flow and Supplemental HTML 27K
Information (Details)
57: R47 Leases - Lease Weighted Average (Details) HTML 26K
58: R48 Leases - Maturities of Operating Lease Liabilities HTML 45K
(Details)
59: R49 Affiliated Companies (Details) HTML 37K
60: R50 Debt - Long-term Debt (Details) HTML 46K
61: R51 Debt - Narrative (Details) HTML 90K
62: R52 Derivative Financial Instruments - Foreign HTML 68K
Exchange Rate and Commodity Price Risk (Details)
63: R53 Derivative Financial Instruments - Effects of HTML 85K
Derivative Instruments on OCI and Earnings
(Details)
64: R54 Fair Value Measurements - Assets and Liabilities HTML 64K
Recorded at Fair Value (Details)
65: R55 Fair Value Measurement - Other Financial HTML 25K
Instruments (Details)
66: R56 Accumulated Other Comprehensive Loss - Components HTML 59K
of Accumulated Other Comprehensive Income
(Details)
67: R57 Accumulated Other Comprehensive Loss - Other HTML 88K
Comprehensive Loss Reclassifications (Details)
68: R58 Shareholder's Equity - Change in Shareholders' HTML 83K
Equity (Details)
69: R59 Shareholder's Equity - Supplemental Equity HTML 23K
Information (Details)
70: R60 Stock-Based Compensation (Details) HTML 58K
71: R61 Benefit Plans - Schedule of Components of Net HTML 64K
Periodic Benefit Cost (Details)
72: R62 Benefit Plans - Narrative (Details) HTML 27K
73: R63 Other (Income) Expense - Summary (Details) HTML 36K
74: R64 Other (Income) Expense - Narrative (Details) HTML 36K
75: R65 Other (Income) Expense - Restructuring and Related HTML 40K
Charges (Details)
76: R66 Other (Income) Expense - Other Items (Details) HTML 35K
77: R67 Income Taxes (Details) HTML 28K
78: R68 Segment Information (Details) HTML 66K
81: XML IDEA XML File -- Filing Summary XML 147K
79: XML XBRL Instance -- wst-20220630_htm XML 3.06M
80: EXCEL IDEA Workbook of Financial Reports XLSX 102K
7: EX-101.CAL XBRL Calculations -- wst-20220630_cal XML 203K
8: EX-101.DEF XBRL Definitions -- wst-20220630_def XML 475K
9: EX-101.LAB XBRL Labels -- wst-20220630_lab XML 1.46M
10: EX-101.PRE XBRL Presentations -- wst-20220630_pre XML 850K
6: EX-101.SCH XBRL Schema -- wst-20220630 XSD 137K
82: JSON XBRL Instance as JSON Data -- MetaLinks 423± 579K
83: ZIP XBRL Zipped Folder -- 0000105770-22-000047-xbrl Zip 283K
 | Download this zipped .zip folder |
| Files: | ex311q22022.htm ex312q22022.htm ex321q22022.htm ex322q22022.htm wst-20220630.htm wst-20220630.xsd wst-20220630_cal.xml wst-20220630_def.xml wst-20220630_lab.xml wst-20220630_pre.xml |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/01/22 West Pharmaceutical Services Inc. 8-K:1,2,9 3/31/22 11:2.4M 2/22/22 West Pharmaceutical Services Inc. 10-K 12/31/21 124:27M Workiva Inc Wde… FA01/FA 10/28/21 West Pharmaceutical Services Inc. 10-Q 9/30/21 83:9.7M 3/01/21 West Pharmaceutical Services Inc. 8-K:5,9 2/23/21 13:402K 7/24/20 West Pharmaceutical Services Inc. 10-Q 6/30/20 87:11M 4/01/19 West Pharmaceutical Services Inc. 8-K:1,2,9 3/28/19 2:3.3M 5/06/99 West Pharmaceutical Services Inc. 10-K 12/31/98 12:372K |